<DOC>
	<DOCNO>NCT00285766</DOCNO>
	<brief_summary>Objective 16-week , open-label study ass safety tolerability daily application three dose STS continuous dose treatment elderly subject major depression . Subjects study visit ( clinic visit ) begin study ( baseline ) study week 1 , 3 , 5 , 8 , 12 , 16 .</brief_summary>
	<brief_title>Safety , Tolerability Efficacy Transdermal System Elderly Subjects With Major Depression</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<criteria>Men/Women good health 65 year old Ability read , understand sign study inform consent Major depression mild severe base rating scale</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2008</verification_date>
	<keyword>Depression</keyword>
</DOC>